Empagliflozin reduces myocardial glucose uptake in persons with type 2 diabetes: a randomised double-blind, placebo-controlled crossover study

被引：0
|
作者：
Lauritsen, K. M. [1 ,2 ]
Gormsen, L. C. [3 ,4 ]
Hansen, T. K. [1 ,2 ]
Nielsen, B. R. R. [5 ]
Johannsen, M. [6 ]
Hansen, J. [6 ]
Wiggers, H. [5 ]
Botker, H. E. [5 ]
Tolbod, L. P. [3 ,4 ]
Moller, N. [1 ,2 ]
Sondergaard, E. [1 ,2 ]
机构：
[1] Aarhus Univ Hosp, Dept Internal Med & Endocrinol, Aarhus, Denmark
[2] Aarhus Univ Hosp, Steno Diabet Ctr Aarhus, Aarhus, Denmark
[3] Aarhus Univ Hosp, Dept Nucl Med, Aarhus, Denmark
[4] Aarhus Univ Hosp, PET Ctr, Aarhus, Denmark
[5] Aarhus Univ Hosp, Dept Cardiol, Aarhus, Denmark
[6] Aarhus Univ Hosp, Dept Forens Med, Aarhus, Denmark
来源：
DIABETOLOGIA | 2020年 / 63卷 / SUPPL 1期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
123
引用
收藏
页码：S62 / S62
页数：1
相关论文
共 50 条
  • [1] Rosiglitazone improves myocardial glucose uptake in ischemic regions in patients with type 2 diabetes.: A 16 week randomised, double-blind, placebo-controlled study
    Lautamäki, R
    Airaksinen, KEJ
    Seppanen, M
    Toikka, J
    Luotolahti, M
    Ball, E
    Borra, R
    Härkönen, R
    Knuuti, J
    Stewart, M
    Nuutila, P
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 197A - 197A
  • [2] Rosiglitazone improves myocardial glucose uptake in patients with type 2 diabetes and coronary artery disease. A 16 week randomised, double-blind, placebo-controlled study
    Lautamaki, R.
    Airaksinen, K. E. J.
    Seppanen, M.
    Ball, E.
    Harkonen, R.
    Stewart, M.
    Knuuti, J.
    Nuutila, P.
    EUROPEAN HEART JOURNAL, 2005, 26 : 578 - 579
  • [3] SGLT2 Inhibition Does Not Affect Myocardial Fatty Acid Oxidation or Uptake, but Reduces Myocardial Glucose Uptake and Blood Flow in Individuals With Type 2 Diabetes: A Randomized Double-Blind, Placebo-Controlled Crossover Trial
    Lauritsen, Katrine M.
    Nielsen, Bent R. R.
    Tolbod, Lars P.
    Johannsen, Mogens
    Hansen, Jakob
    Hansen, Troels K.
    Wiggers, Henrik
    Moller, Niels
    Gormsen, Lars C.
    Sondergaard, Esben
    DIABETES, 2021, 70 (03) : 800 - 808
  • [4] Baclofen reduces binge eating in a double-blind, placebo-controlled, crossover study
    Corwin, Rebecca L.
    Boan, Jarol
    Peters, Kathryn F.
    Ulbrecht, Jan S.
    BEHAVIOURAL PHARMACOLOGY, 2012, 23 (5-6): : 616 - 625
  • [5] Effects of tonabersat on migraine with aura: a randomised, double-blind, placebo-controlled crossover study
    Hauge, Anne W.
    Asghar, Mohammed S.
    Schytz, Henrik W.
    Christensen, Karl
    Olesen, Jes
    LANCET NEUROLOGY, 2009, 8 (08): : 718 - 723
  • [6] Empagliflozin monotherapy with sitagliptin as an active comparator in patients with type 2 diabetes: a randomised, double-blind, placebo-controlled, phase 3 trial
    Roden, Michael
    Weng, Jianping
    Eilbracht, Jens
    Delafont, Bruno
    Kim, Gabriel
    Woerle, Hans J.
    Broedl, Uli C.
    LANCET DIABETES & ENDOCRINOLOGY, 2013, 1 (03): : 208 - 219
  • [7] The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
    Laurence Lion-François
    François Gueyffier
    Catherine Mercier
    Daniel Gérard
    Vania Herbillon
    Isabelle Kemlin
    Diana Rodriguez
    Tiphanie Ginhoux
    Emeline Peyric
    Virginie Coutinho
    Valentine Bréant
    Vincent des Portes
    Stéphane Pinson
    Patrick Combemale
    Behrouz Kassaï
    Orphanet Journal of Rare Diseases, 9
  • [8] The effect of methylphenidate on neurofibromatosis type 1: a randomised, double-blind, placebo-controlled, crossover trial
    Lion-Francois, Laurence
    Gueyffier, Francois
    Mercier, Catherine
    Gerard, Daniel
    Herbillon, Vania
    Kemlin, Isabelle
    Rodriguez, Diana
    Ginhoux, Tiphanie
    Peyric, Emeline
    Coutinho, Virginie
    Breant, Valentine
    des Portes, Vincent
    Pinson, Stephane
    Combemale, Patrick
    Kassai, Behrouz
    ORPHANET JOURNAL OF RARE DISEASES, 2014, 9 : 142
  • [9] Empagliflozin reduces blood pressure in patients with Type 2 diabetes and hypertension: a phase III, randomised, double-blind, placebo-controlled trial (EMPA-REG BP™)
    Tikkanen, I.
    Narko, K.
    Zeller, C.
    Green, A.
    Salsali, A.
    Broedl, U. C.
    Woerle, H. J.
    DIABETIC MEDICINE, 2014, 31 : 64 - 64
  • [10] A PLACEBO-CONTROLLED, DOUBLE-BLIND CROSSOVER STUDY OF FLUOXETINE IN TRICHOTILLOMANIA
    CHRISTENSON, GA
    MACKENZIE, TB
    MITCHELL, JE
    CALLIES, AL
    AMERICAN JOURNAL OF PSYCHIATRY, 1991, 148 (11): : 1566 - 1571
12345